Western Cape health practitioners address COVID-19 myths georgeherald.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from georgeherald.com Daily Mail and Mail on Sunday newspapers.
Stephen Lawn Memorial Lecture 2021 lshtm.ac.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lshtm.ac.uk Daily Mail and Mail on Sunday newspapers.
The ânext generationâ vaccines are being developed in SA
By Nathan Craig
Share
Durban - Two Covid-19 vaccines were being refined in the country with the potential to outsmart current and future variants â strengthening the fight against the pandemic.
Shantivax and had5, were considered to be the next-generation Covid-19 vaccines.
GENLAB, a Gqeberha (formerly Port Elizabeth) based immunotherapy company, and Danish biotechnology company, Immunitrack, were behind Shantivax â the first Covid-19 vaccine of African origin.
The had5 Covid-19 vaccine was designed by Immunitybio Inc, an immunotherapy company from California with a lineage in cancer treatments, along with researchers from the University of Cape Town.
A variant-proof vaccine? Two California firms launch trials of COVID shot they hope will protect against the South African form - and future mutants - by targeting a more stable part of the infectious spike protein
Two biotechnology companies based in California, ImmunityBio and NantKwest, are beginning Phase I clinical trials of their vaccine in South Africa
Their candidate, hAd5 T-cell, targets two parts of the virus: the spike protein, more prone to mutations and the nucleocapsid protein, which is less prone
Researchers hope this will help protect against variants of the coronavirus like those that arose in the UK, South Africa and Brazil